Literature DB >> 26010531

Coronary artery calcification score is an independent predictor of the no-reflow phenomenon after reperfusion therapy in acute myocardial infarction.

Rodrigo Modolo1, Valeria N Figueiredo, Filipe A Moura, Breno Almeida, José C Quinaglia e Silva, Wilson Nadruz, Pedro A Lemos, Otavio R Coelho, Michael J Blaha, Andrei C Sposito.   

Abstract

AIM/
BACKGROUND: Abundant evidence shows that coronary artery calcification (CAC) is a strong marker of structural and functional changes within the artery wall. Thus far, the implications of CAC in patients with acute coronary syndromes remain unclear. We aimed to investigate whether the CAC score is associated with impaired reperfusion during the acute phase of ST-elevation myocardial infarction (STEMI).
METHODS: We enrolled 60 consecutive STEMI patients to undergo cardiac computed tomography for assessment of the CAC score within 1 week after STEMI. Coronary thrombus burden, coronary blood flow (TIMI flow), and myocardial blush grade (MBG) were evaluated systematically. Patients with maximal TIMI flow and MBG were grouped as optimal reperfusion (n=27) and their counterparts as no-reflow (NR, n=33).
RESULTS: There were no differences in the clinical characteristics between groups. Patients in the NR group had higher heart rate, coronary angiographic severity, and CAC score. CAC score greater than 100 was associated independently with the presence of NR (odds ratio 4.4, 95% confidence interval 1.17-16.3). The CAC score of nonculprit coronary arteries was higher in NR individuals than in their counterparts (P=0.04). In addition, the CAC score of the isnfarct-related artery correlated negatively with the TIMI-flow rate (r=-0.54, P<0.001) and with the MBG (r=-0.32, P=0.04).
CONCLUSION: The CAC score is associated with the presence of the NR phenomenon in STEMI patients.

Entities:  

Mesh:

Year:  2015        PMID: 26010531     DOI: 10.1097/MCA.0000000000000269

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  2 in total

1.  Evaluation of related factors, prediction and treatment drugs of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction after direct PCI.

Authors:  Hui Li; Du-Guan Fu; Fu-Yuan Liu; Heng Zhou; Xiao-Mei Li
Journal:  Exp Ther Med       Date:  2018-02-27       Impact factor: 2.447

2.  Relationship between alkaline phosphatase and impaired coronary flow in patients with ST-segment elevated myocardial infarction.

Authors:  Efe Edem
Journal:  J Int Med Res       Date:  2018-07-05       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.